Prestige Consumer Healthcare (PBH) Depreciation & Amortization (CF) (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Depreciation & Amortization (CF) of $7.6 million for Q4 2025, up 10.54% year-over-year from $6.9 million in Q4 2024, and down 0.93% quarter-over-quarter from $7.7 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $7.6 million for Q4 2025.
- In Q4 2025, Depreciation & Amortization (CF) rose 10.54% year-over-year to $7.6 million; the TTM figure through Dec 2025 stood at $30.2 million (down 1.92% YoY), while the FY2025 annual figure was $30.2 million, down 1.64% from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 stood at $7.6 million, down from $7.7 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $8.5 million in Q1 2022, with the low at $6.9 million in Q4 2024.
- The 5-year median for Depreciation & Amortization (CF) is $7.8 million (2024), against an average of $7.8 million.
- The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) rose 12.58% in 2022, then declined 10.18% in 2024.
- Prestige Consumer Healthcare's Depreciation & Amortization (CF) stood at $8.0 million in 2021, then rose by 0.99% to $8.1 million in 2022, then fell by 5.95% to $7.6 million in 2023, then slipped by 10.18% to $6.9 million in 2024, then climbed by 10.54% to $7.6 million in 2025.
- Business Quant data shows PBH's Depreciation & Amortization (CF) at $7.6 million in Q4 2025, $7.7 million in Q3 2025, and $7.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.59 Mn |
| Dec 31, 2025 | 7.59 Mn |
| Sep 30, 2025 | 7.66 Mn |
| Sep 30, 2025 | 7.66 Mn |
| Jun 30, 2025 | 7.67 Mn |
| Jun 30, 2025 | 7.67 Mn |
| Mar 31, 2025 | 7.25 Mn |
| Mar 31, 2025 | 7.25 Mn |
| Dec 31, 2024 | 6.87 Mn |
| Dec 31, 2024 | 6.87 Mn |
| Sep 30, 2024 | 7.93 Mn |
| Sep 30, 2024 | 7.93 Mn |
| Jun 30, 2024 | 8.12 Mn |
| Jun 30, 2024 | 8.12 Mn |
| Mar 31, 2024 | 7.84 Mn |
| Mar 31, 2024 | 7.84 Mn |
| Dec 31, 2023 | 7.65 Mn |
| Dec 31, 2023 | 7.65 Mn |
| Sep 30, 2023 | 7.64 Mn |
| Sep 30, 2023 | 7.64 Mn |